U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07486986) titled 'Endocrine Disruption, Menopause, and Poor Sleep in wOmen With Type 2 Diabetes: Effects on Cardiovascular Health' on March 17.
Brief Summary: EMPOWER aims to determine the overall effect of menopause and sleep disruption on cardiac remodeling in women with type 2 diabetes.
Study Start Date: April, 2026
Study Type: OBSERVATIONAL
Condition:
Menopause
Sleep Disruption
T2DM
Intervention:
OTHER: 4 years of clinical evaluations.
The intervention in this study is the additional clinical evaluations for women with type 2 DM and in perimenopause.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ottawa Heart Institute Research Corpora...